篠田 肇

Medicine & Life Sciences

1. Eye 100%
2. Vitrectomy 84%
3. Macular Degeneration 67%
4. Visual Acuity 62%
5. Retinal Perforations 58%
6. Temazepam 47%
7. Macular Pigment 45%
8. Choroidal Neovascularization 39%
9. Epiretinal Membrane 39%
10. Ranibizumab 36%
11. Macular Edema 34%
12. Optical Coherence Tomography 30%
13. Vascular Endothelial Growth Factor A 29%
14. Retinal Detachment 27%
15. aflibercept 27%
16. Retina 25%
17. Diabetic Retinopathy 19%
18. Retinal Vein Occlusion 18%
19. Physiologic Neovascularization 18%
20. Endothelial Growth Factors 17%
21. Retinal Neovascularization 16%
22. Intravitreal Injections 16%
23. Uveitis 15%
24. Angiotensin Type 1 Receptor 15%
25. Triamcinolone Acetonide 15%
26. Visual Fields 15%
27. Intercellular Adhesion Molecule-1 14%
28. Inflammation 14%
29. Scleral Buckling 14%
30. Cannula 13%
31. Endotoxins 12%
32. Type II Macular Corneal Dystrophy 12%
33. Retinal Pigment Epithelium 12%
34. Lutein 12%
35. University Hospitals 11%
36. Lasers 11%
37. Renin 11%
38. prorenin receptor 11%
39. Therapeutics 11%
40. Serum 11%
41. Telmisartan 11%
42. Cataract 11%
43. Retinal Vessels 11%
44. Intraocular Pressure 10%
45. Confidence Intervals 10%
46. Ocular Vision 10%
47. Hypoxia 10%
48. Injections 9%
49. Anesthesia 9%
50. Choroid Hemorrhage 9%